NAD+ IV Therapy

Nicotinamide adenine dinucleotide (NAD+) intravenous infusion to support cellular energy production, DNA repair, and neurological function — a cornerstone of the clinic's longevity programme.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme critical to cellular energy metabolism, DNA repair, and the activation of sirtuins — longevity-associated proteins implicated in ageing and metabolic regulation. NAD+ levels decline significantly with age, and intravenous supplementation is one of the most direct methods to restore cellular concentrations. Nuffield Medical offers NAD+ IV infusions as a standalone treatment or as part of the Longevity Programme Assessment (LPA) protocol, administered at the Orchard or Siglap clinic by trained nurses under doctor supervision. A standard NAD+ infusion delivers 250–500 mg of pharmaceutical-grade NAD+ diluted in normal saline, infused slowly over 2–4 hours to minimise the flushing and nausea that can occur with rapid administration. Patients typically report improved mental clarity, sustained energy levels, and enhanced recovery in the days following infusion. A course of 3–10 sessions is often recommended depending on individual goals — whether targeting cognitive enhancement, athletic recovery, post-illness recuperation, or general anti-ageing. The clinic's medical team monitors each session and can adjust the infusion rate for comfort. NAD+ therapy at Nuffield Medical is embedded within a clinical framework: patients are assessed for suitability and the treatment is positioned as a medically supervised intervention rather than a wellness trend. This positions it as one of the more credible NAD+ offerings in Singapore's growing longevity market.